1 | partnership to promote the | | | | | | | 2 | 0.13% |
2 | to counterfeit or mishandled | | | | | | | 2 | 0.13% |
3 | portsmouth secures £250k for | | | | | | | 2 | 0.13% |
4 | secures £250k for innovative | | | | | | | 2 | 0.13% |
5 | £250k for innovative xray | | | | | | | 2 | 0.13% |
6 | drug targets unveiled through | | | | | | | 2 | 0.13% |
7 | shapeshifting cancer cell discovery | | | | | | | 2 | 0.13% |
8 | recipient of historic pig | | | | | | | 2 | 0.13% |
9 | cancer cell discovery dermatologist | | | | | | | 2 | 0.13% |
10 | or mishandled botulinum toxin | | | | | | | 2 | 0.13% |
11 | counterfeit or mishandled botulinum | | | | | | | 2 | 0.13% |
12 | linked to counterfeit or | | | | | | | 2 | 0.13% |
13 | university of portsmouth secures | | | | | | | 2 | 0.13% |
14 | incidents linked to counterfeit | | | | | | | 2 | 0.13% |
15 | adverse incidents linked to | | | | | | | 2 | 0.13% |
16 | probing adverse incidents linked | | | | | | | 2 | 0.13% |
17 | cdc probing adverse incidents | | | | | | | 2 | 0.13% |
18 | kidney transplant passes away | | | | | | | 2 | 0.13% |
19 | transplant passes away weeks | | | | | | | 2 | 0.13% |
20 | targets relief for skin | | | | | | | 2 | 0.13% |
21 | analysis by ons reveals | | | | | | | 2 | 0.13% |
22 | by ons reveals 30 | | | | | | | 2 | 0.13% |
23 | of portsmouth secures £250k | | | | | | | 2 | 0.13% |
24 | cancer drug targets unveiled | | | | | | | 2 | 0.13% |
25 | pioneers nonsurgical treatment for | | | | | | | 2 | 0.13% |
26 | afford a fastaging population | | | | | | | 2 | 0.13% |
27 | astrazeneca pulls covid vaccine | | | | | | | 2 | 0.13% |
28 | the latest advances in | | | | | | | 2 | 0.13% |
29 | promote the latest advances | | | | | | | 2 | 0.13% |
30 | to promote the latest | | | | | | | 2 | 0.13% |
31 | intelligence with societies unable | | | | | | | 2 | 0.13% |
32 | with societies unable to | | | | | | | 2 | 0.13% |
33 | societies unable to afford | | | | | | | 2 | 0.13% |
34 | unable to afford a | | | | | | | 2 | 0.13% |
35 | to afford a fastaging | | | | | | | 2 | 0.13% |
36 | a fastaging population we | | | | | | | 2 | 0.13% |
37 | skin cancer drug targets | | | | | | | 2 | 0.13% |
38 | pulls covid vaccine from | | | | | | | 2 | 0.13% |
39 | covid vaccine from global | | | | | | | 2 | 0.13% |
40 | vaccine from global distribution | | | | | | | 2 | 0.13% |